The Allergen Bureau mission is for consistent, science-based, allergen risk assessment & labelling. This is to be achieved through a globally accepted and consistent approach to food allergen risk assessment, management and communication (labelling), including incidental trace allergen risk quantification, that:
- guides industry best practice;
- complements allergen labelling regulations; and
- enables allergen sensitive consumers to confidently make choices based on label information.
Allergen Bureau representation at recent international events have sought to further these objectives.
130th AOAC Annual Meeting, Dallas, Texas, September 2016
Allergen Bureau Director, Rob Sherlock (DTS FACTA), had an opportunity to present at the 130th AOAC Annual Meeting & Exposition of the Association of Analytical Communities in Dallas.
This was a fantastic opportunity to participate in a meeting that covered Analytics, Analytical Methods, Analytical Techniques and Environmental Analysis and to present on ‘The VITAL Approach to risk-based precautionary labelling’. The presentation provided a brief unpacking of the principles of the VITAL Program, key concepts and its practical elements. Rob’s presentation provided an opportunity to highlight the work done by the VITAL Scientific Expert Panel (VSEP), the launch of VITAL Online and the ongoing development of the Allergen Bureau Working groups and their outputs.
The meeting was well attendee overall and the sessions dealing specifically with food allergens were all fully subscribed. The AOAC has initiated a number of working groups related to the challenges of food allergen analysis and we look forward to the outcomes from these groups
View Robin’s presentation here http://allergenbureau.net/wp-content/uploads/2016/10/AOAC_Dallas_1.pdf
In October 2016, Rob and Allergen Bureau Director, Kirsten Grinter (Nestlé Australia) were able to represent the Allergen Bureau at the 7th and penultimate iFAAM Consortium Meeting. IFAAM is the world’s largest study of allergies – spearheaded by the University of Manchester – and began in March 2013. The iFAAM consortium consists of 38 Partner Organizations and the Allergen Bureau has participated as an Associate Member. It was a great experience to be able to participate in the meetings and contribute to the work being done by the iFAAM members as this huge project draws to a close. The work will contribute to shaping the future of food allergy diagnosis, patient management and food industry responses. The final meeting will take place in Madrid in 2017 and we look forward to the outputs of this globally significant project.
4th Food Allergy and Anaphylaxis Meeting, Rome, Italy, October 2016
Prior to the iFAAM meeting, Kirsten gave a presentation on ‘VITAL – our priorities and challenges’ at the European Academy of Allergy & Clinical Immunology 4th Food Allergy and Anaphylaxis Meeting.
The 4th FAAM meeting reflected a strong presence of all stakeholders including allergists, pediatricians, gastroenterologists, food technologists, allied health, policy makers and patient’s organisations. This multi-professional arena is seen as crucial in getting a holistic approach of the several clinical manifestations of food allergy, embracing the community and the daily life of patients.
View Kirsten’s presentation here http://allergenbureau.net/wp-content/uploads/2016/10/VITAL_ITALY.pdf